21571 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Sub-classes:[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF
#2Peptide Composition for Cancer Approach and Diagnosis
#3FLUORINATION PROCESS
#4ANTI-CANCER STRAIN EXPRESSING STREP-TAG, ANTI-CANCER COMPOSITION USING THE SAME, ANTI-CANCER ADJUVANT AND TUMOR IMAGING AGENT
#5COMPOSITIONS OF AND METHODS OF MAKING FERRITIN-BASED IMAGING AGENTS
#6IMMUNORECEPTOR INHIBITORY PROTEINS AND RELATED METHODS
#7RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS
#8DLL3-SPECIFIC BINDING CONSTRUCTS AND THEIR USE IN RADIOTHERAPY
#9METAL-BINDING POLYPEPTIDE
#10AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#11BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP
#12INJECTABLE AND/OR SPRAYABLE, IN SITU POLYMERIZABLE COLLAGEN COMPOSITIONS FOR SUSTAINED DELIVERY OF THERAPEUTICS
#13METHODS FOR INHIBITING TRAINED IMMUNITY WITH NANOBIOLOGIC COMPOSITIONS
#14FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDES
#15FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDES
#16FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDES
#17METHODS USING SURFACE-EXPRESSIBLE ACTIVATABLE EPITOPES TO LOCALIZE AND/OR TREAT DISEASED CELLS
#18MASKED IL12 PROTEIN
#19PSMA-TARGETED RADIOPHARMACEUTICALS AND CHECKPOINT INHIBITOR COMBINATION THERAPY
#20STABILIZED RADIOPHARMACEUTICAL COMPOSITION
#21ACTIVATION OF BIOLUMINESCENCE BY STRUCTURAL COMPLEMENTATION
#22METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY
#23Nanoparticles Having Molecules That Bind or Block PD-L1 and Uses In Treating Cancer
#24Radiolabeled GRPR-Antagonists for Diagnostic Imaging and Treatment of GRPR-Positive Cancer
#25DIAGNOSTIC AND THERAPEUTIC RADIOPHARMACEUTICALS FROM TRIMERIC AMINO ACID MATRIX
#26METHODS FOR DETECTING CCR2 RECEPTORS
#27TARGETING SORTILIN
#28F-18-LABELED COMPOUND FOR POSITRON EMISSION TOMOGRAPHY OF DEAD CELLS AND PREPARATION METHOD THEREFOR
#29LAG-3 PROTEIN MUTANT, AND PREPARATION AND USE THEREOF
#30LIGANDS OF THE FSH HORMONE RECEPTOR IN THE DIAGNOSIS AND TREATMENT OF TUMORS
#31NOVEL HUMAN PROGRAMMED DEATH LIGAND 1 (PD-L1) SPECIFIC BINDING MOLECULES
#32CANCER-SPECIFIC POLYPEPTIDE AND USE THEREOF
#33NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS
#34HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE
#35PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS
#36NEW HER2-BINDING POLYPEPTIDE
#37Dual-Mode Pharmaceutical Composition for Peptide-Specific Targeted Positron Emission Tomography and Boron Neutron Capture Therapy and the Use Thereof
#38Bicyclic peptide ligands specific for MT1-MMP
#39Molecular imaging complex for positron emission tomography
#40COMPOSITIONS TARGETING TUMOR ASSOCIATED MACROPHAGES AND METHODS USING SAME
#41PROTEASE-ACTIVATED CONTRAST AGENTS FOR IN VIVO IMAGING
#42MACROPINOCYTOSIS SELECTIVE MONOBODY-DRUG CONJUGATES
#43METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY
#44METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY
#45Nanoparticles having molecules that bind or block PD-L1 and uses in treating cancer
#46SMALL MOLECULE DRUG CONJUGATES
#47BIOORTHOGONAL REPORTER GENE SYSTEM
#48CARTILAGE-HOMING PEPTIDES
#49Granzyme B directed imaging and therapy
#50EPCAM BINDING FIBRONECTIN TYPE III DOMAINS
#51METHODS FOR DIAGNOSING AND MONITORING EOSINOPHILIC ESOPHAGITIS
#52METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER
#53PEPTIDES AND FORMULATIONS FOR CANCER TREATMENT
#54COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF
#55Tissue-homing peptide conjugates and methods of use thereof
#56CHROMOGRANIN A-DERIVED PEPTIDES AND USES THEREOF
#57CYCLIC PEPTIDES AS PROTEIN TARGETING AGENTS
#58SYSTEMS AND METHODS FOR CREATING CUSTOM BRACHYTHERAPY CARRIERS
#59CUSTOM BRACHYTHERAPY CARRIERS
#60PHARMACEUTICAL FORMULATIONS AND METHODS FOR DELIVERING A THERAPEUTIC, DIAGNOSTIC, OR IMAGING AGENT TO CD206
#61MUTANTS AND DRUG CONJUGATES OF R-SPONDINS AND USE THEREOF
#62POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING
#63INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES
#64Compositions of and methods of making ferritin-based imaging agents
#65FLUORINATION METHOD
#66DEVICES AND METHODS FOR RADIOPHARMACEUTICAL SYNTHESIS
#67COMPOSITION FOR TARGETING MEDULLARY THYROID CANCER
#68Method of detecting eosinophil degranulation in the respiratory tract
#69MUTANT VARIANTS OF PD-1 RECEPTOR WITH SELECTIVE BINDING TO PD-L1 AND USES THEREOF
#70BIODEGRADABLE ADHESIVE WITH RADIOISOTOPES
#71Bicyclic peptide ligands specific for MT1-MMP
#72COMPOSITION COMPRISING CATALASE, PREPARATION METHOD AND USE THEREOF AND METHOD FOR KILLING TUMOR CELLS
#73Chelating AAZTA conjugates and complexes thereof
#74Cartilage-homing peptides
#75PET TRACER FOR IMAGING OF NEUROENDOCRINE TUMORS
#76Radiolabeled GRPR-Antagonists for Diagnostic Imaging and Treatment of GRPR-Positive Cancer
#77Enhanced in Vivo Targeting of Site-Specific Drugs
#78PD-L1 binding polypeptides for imaging
#79COMPOSITIONS AND METHODS FOR DETECTING ACE2 EXPRESSION PROFILES
#80Recombinant lectin and uses thereof
#81Cyclic Peptide
#82Stable, concentrated radionuclide complex solutions
#83Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#84CD31SHED AS A MOLECULAR TARGET FOR IMAGING OF INFLAMMATION
#85Radiolabeled GRPR-antagonists for diagnostic imaging and treatment of GRPR-positive cancer
#86Radiolabeled GRPR-antagonists for diagnostic imaging and treatment of GRPR-positive cancer
#87DESIGN AND DEVELOPMENT OF NEUROKININ-1 RECEPTOR-BINDING AGENT DELIVERY CONJUGATES
#88Method for extraction and purification of 68GA
#89Small Molecule Drug Conjugates
#90METHODS FOR ENHANCING PERMEABILITY TO BLOOD-BRAIN BARRIER, AND USES THEREOF
#91METHODS OF SEQUESTERING TARGET ELEMENTS
#92CARTILAGE-HOMING PEPTIDE CONJUGATES AND METHODS OF USE THEREOF
#93Tandem repeat cancer-targeting peptides for molecular conjugation or engineering and uses thereof in cancer theranostics
#94Methods of diagnosing and treating cervical cancer or a high-grade cervical lesion based on expression of ankyrin-3
#95Prostate specific membrane antigen binding fibronectin type iii domains
#96ACCUMULATIVE BORON 10 MEDICINE FOR BORON NEUTRON CAPTURE THERAPY FOR SELECTIVELY OR LOCALLY TARGETING TUMOR TISSUES IN SHORT TIME
#97Cyclic peptides as protein targeting agents
#98TAU KINETIC MEASUREMENTS
#99Methods of diagnosing and treating cervical cancer based on expression of farnesyl pyrophosphate synthase
#100High affinity PD-1 agents and methods of use
#101Methods of diagnosing and treating cervical cancer
#102Methods for detecting CCR2 receptors
#103Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging
#10418F labeling of proteins using sortases
#105Composition comprising catalase, preparation method and use thereof and method for killing tumor cells
#106NANOBIOLOGIC COMPOSITIONS FOR INHIBITING TRAINED IMMUNITY
#107SYSTEMS AND METHODS FOR RAPID NEURAL NETWORK-BASED IMAGE SEGMENTATION AND RADIOPHARMACEUTICAL UPTAKE DETERMINATION
#108Peptides for molecular detection of PD-L1
#109PROTEASE-ACTIVATED CONTRAST AGENTS FOR IN VIVO IMAGING
#110Activation of bioluminescene by structural complementation
#111Bicyclic peptide ligands specific for MT1-MMP
#112Positron emitting radionuclide labeled peptides for human uPAR PET imaging
#113Dual targeting ligand for cancer diagnosis and treatment
#114Bicyclic peptide ligands specific for MT1-MMP
#115Peptide libraries with non-canonical amino acids
#116COMPOUNDS WITH REDUCED RING SIZE FOR USE IN DIAGNOSING AND TREATING MELANOMA, INCLUDING METASTATIC MELANOMA AND METHODS RELATED TO SAME
#117Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors
#118Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#119Cartilage-homing peptide conjugates and methods of use thereof
#120Stable, concentrated radionuclide complex solutions
#121Stable, concentrated radionuclide complex solutions
#122Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment
#123Methods for diagnosing and monitoring eosinophilic esophagitis
#124Radiolabeled GRPR-antagonists for diagnostic imaging and treatment of GRPR-positive cancer
#125MOLECULAR IMAGING CONTRAST AGENTS AND USES THEREOF
#126Clearing agent
#127Kit for radiolabelling
#128PD-L1 binding polypeptides for imaging
#129Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
#130PET tracer for imaging of neuroendocrine tumors
#131PEPTIDES AND METHODS OF USE THEREOF
#132Inhibitor-functionalized ultrasmall nanoparticles and methods thereof
#133Nanoparticles Having Molecules That Bind or Block PD-L1 and Uses In Treating Cancer
#134SINGLE VARIABLE DOMAIN T-CELL RECEPTORS
#135RECOMBINANT LECTIN AND USES THEREOF
#136Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#137Granzyme B directed imaging and therapy
#13818F labeled amino acids, derivatives thereof and method of making same
#139ANTICANCER THERAPY
#140INHIBITORS
#141AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#142Cartilage-homing peptides
#143Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
#144CD31 as a molecular target for imaging of inflammation
#145Radiolabeled drug
#146PET tracer for imaging of neuroendocrine tumors
#147NOVEL POLYPEPTIDES WITH IMPROVED PROTEOLYTIC STABILITY, AND METHODS OF PREPARING AND USING SAME
#148ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN CONNECTION WITH USE OF CONTRAST MEDIA
#149Cyclotides as immunosuppressive agents
#150VARIANTS OF AMYLOID beta-PROTEIN PRECURSOR INHIBITOR DOMAIN
#151RADIOLABELED DISINTEGRINS AS BRACHYTHERAPY AGENTS
#152Systems and methods for minimally-invasive assessment of toxicity-induced tissue injury
#153Activation of bioluminescence by structural complementation
#154Activation of bioluminescence by structural complementation
#155Liposomal formulation for the oral hepatic delivery of drugs
#156RECEPTOR-BINDING DOMAINS LIGANDS FOR THE DETECTION, DIAGNOSIS AND TREATMENT OF PANCREATIC CANCER
#157Bicyclic peptide ligands specific for MT1-MMP
#158Small Molecule Drug Conjugates
#159Kit for radiolabelling
#160EpCAM targeted polypeptides, conjugates thereof, and methods of use thereof
#161Alpha-1-microglobulin for use in the protection of kidneys in radionuclide therapy
#162Environmentally sensitive compositions comprising a pH-triggered membrane protein and methods of use thereof in the treatment and diagnosis of tumors
#163Conjugates that are configured for targeted delivery of therapeutic compounds to senescent cells
#164Activation of bioluminescence by structural complementation
#165POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING
#166EVALUATION OF PRESENCE OF AND VULNERABILITY TO ATRIAL FIBRILLATION AND OTHER INDICATIONS USING MATRIX METALLOPROTEINASE-BASED IMAGING
#167METHOD AND SYSTEM FOR PRODUCING GALLIUM-68 RADIOISOTOPE BY SOLID TARGETING IN A CYCLOTRON
#168Peptidomimetics for imaging the ghrelin receptor
#169Inhibitors of mitochondrial fission and methods of use thereof
#170Activation of bioluminescence by structural complementation
#171Cathepsin-binding compounds bound to a carrier and their diagnostic use
#172Inhibitors of growth factor activation enzymes
#173Modified cyclopentapeptides and uses thereof
#174Methods for diagnosing and monitoring eosinophilic esophagitis
#175Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
#176Ruthenium and Indium Binding to Gastrins
#177Conjugates for protection from nephrotoxic active substances
#178Process for the purification of Ga-68 from eluate deriving from Ge/Ga generators and chromatographic columns for use in said process
#179Protease-activated contrast agents for in vivo imaging
#180Collagen targeted imaging probes
#181Functionalized linear ligands and complexes thereof
#182COMPOSITIONS AND METHODS FOR DETECTING CCR2 RECEPTORS
#183Peptides for targeting colorectal cancer, and medical use thereof
#184NEUROTOXIC TARGET FOR AMYLOSPHEROID, METHOD AND MATERIAL FOR REDUCING THE NEUROTOXICITY OF AMYLOSPHEROID, AND USE THEREOF
#185CD8-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#186Inhibitors of mitochondrial fission and methods of use thereof
#187Tau kinetic measurements
#188Anticancer therapy
#189Therapeutic inhibitor for EBV-associated tumor with tailor responsive optical imaging
#190METHODS FOR ENHANCING PERMEABILITY TO BLOOD-BRAIN BARRIER, AND USES THEREOF
#191Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
#192PD-L1 binding polypeptides for imaging
#193Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising same
#194Fluorescent silica-based nanoparticles
#195Cyclotides as immunosuppressive agents
#196High affinity PD-1 agents and methods of use
#197Hydrophobin mimics: process for preparation thereof
#198Small molecule drug conjugates
#199Development of neurokinin-1 receptor-binding agent delivery conjugates
#200Polypeptides targeting vascular endothelial growth factor receptor and prostate specific membrane antigen
#201NOVEL COMPOUNDS COMPRISING A BOMBESIN DERIVATIVE, A PROCESS FOR THE PREPARATION THEREOF AND A NUCLEAR MOLECULAR IMAGING AGENT COMPRISING THE SAME
#202Bacteriophage gene 3 protein compositions and use as amyloid binding agents
#203Drug conjugates for delivering compounds to senescent cells
#204LIPOCALIN MUTEINS WITH BINDING-AFFINITY FOR GLYPICAN-3 (GPC-3) AND USE OF LIPOCALIN MUTEINS FOR TARGET-SPECIFIC DELIVERY TO CELLS EXPRESSING GPC-3
#205Engineered fluorinated biomaterials
#206METHODS OF IMAGING WITH Ga-68 LABELED MOLECULES
#207Tumor-targeting polypeptide and application thereof
#208LIPIDATED GLYCOPROTEIN PARTICLES AND METHODS OF USE
#209ANTIBODIES REACTIVE WITH AN EPITOPE LOCATED IN THE N-TERMINAL REGION OF MUC5AC COMPRISING CYSTEINE-RICH SUBDOMAIN 2 (CYS2)
#210Activatable fibrin-binding probes
#211Prostate specific membrane antigen binding fibronectin type III domains
#212COMPOUNDS AND COMPOSITIONS FOR IMAGING GCC-EXPRESSING CELLS
#213METHODS TO DIAGNOSE DEGENERATIVE DISC DISEASE
#214Activation of bioluminescence by structural complementation
#215Positron emitting radionuclide labeled peptides for human uPAR PET imaging
#216Imaging beta cell mass
#217Environmentally sensitive compositions and methods of use thereof
#218Akt-specific capture agents, compositions, and methods of using and making
#219Leukemia stem cell targeting ligands and methods of use
#220Somatostatin analogs with inhibitory activity to growth hormone release
#221METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY
#222Ligands to radiation-induced molecules
#223Peptides and peptide/active compound conjugates for renal targeting
#224Radiolabelling method
#225ANALOGS OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND METHODS FOR THEIR USE
#226GRP-R agonistic 177-lutetium-labeled bombesin derivatives for diagnosis and treatment of prostate cancer
#227Inhibitors of mitochondrial fission and methods of use thereof
#228Conjugates for protection from nephrotoxic active substances
#229Detection of early-stage pancreatic adenocarcinoma
#230High affinity PD-1 agents and methods of use
#231High affinity PD-1 agents and methods of use
#232Cyclotides as immunosuppressive agents
#233Porphyrin modified telodendrimers
#234THERAPEUTIC AGENTS
#235KIT FOR TUMOR IMAGING
#236Treatment of metastatic tumors
#237BRAIN TUMOR TARGETING PEPTIDES AND METHODS
#238Polypeptide and imaging method
#239ErbB-2 RECEPTOR TARGETING PEPTIDE
#240Antibodies reactive with an epitope located in the N-terminal region of MUC5AC comprising cysteine-rich subdomain 2 (Cys2)
#241Radiolabeled GRPR-antagonists for diagnostic imaging and treatment of GRPR-positive cancer
#242Molecular imaging contrast agents and uses thereof
#243Labelled adrenomedullin derivatives and their use for imaging and therapy.
#244Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
#245MOLECULAR PROBE FOR IMAGING OF PANCREATIC ISLET AND THE PRECURSOR, AND USE OF THE SAME
#246Peptides that specifically bind HGF receptor (cMet) and uses thereof
#247PSMA-targeting imaging agents
#248Anticancer therapy
#249Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
#250Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#251Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
#252Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
#253COMPOSITIONS AND METHODS FOR DETECTING OR ELIMINATING SENESCENT CELLS TO DIAGNOSE OR TREAT DISEASE
#254Methods for diagnosing and monitoring eosinophilic esophagitis
#255Small peptide specific for lung cancer and application thereof
#256METHOD AND COMPOSITION FOR TREATING CANCER
#257Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors
#258Controlled synthesis of polyglutamates with low polydispersity and versatile architectures
#259Cyclic peptides as protein targeting agents
#260COMPOSITIONS AND METHODS FOR IMAGING INFLAMMATION OF TRAUMATIC BRAIN INJURY
#261Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
#262EVALUATION OF PRESENCE OF AND VULNERABILITY TO ATRIAL FIBRILLATION AND OTHER INDICATIONS USING MATRIX METALLOPROTEINASE-BASED IMAGING
#263DIAGNOSIS AND TREATMENT OF TUMORS
#264Recognition molecules for the treatment and detection of tumors
#265Methods and compositions for treating disorders
#266Radiofluorination method
#267Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
#268Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#269CYCLOTIDES AS IMMUNOSUPPRESSIVE AGENTS
#270Ligands to radiation-induced molecules
#271Activation of bioluminescence by structural complementation
#272Therapeutic approach for polyglutamine degeneration
#273Activation of bioluminescence by structural complementation
#274Pet tracer for imaging of neuroendocrine tumors
#275Anti-met therapy for previously diagnosed cancer patients
#276Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging
#277Inhibitors of mitochondrial fission and methods of use thereof
#278ASTHMA IMAGING
#279Method of labelling a biologically active molecule with 5-fluoro-5-deoxypentose or a 3-fluoro-3-deoxypentose
#280Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#281Cathepsin-binding compounds bound to a carrier and their diagnostic use
#282Somatostatin analogs with inhibitory activity to growth hormone release
#283Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides
#284In vivo methods of monitoring biodistribution
#285Porphyrin modified telodendrimers
#286Compounds for diagnosing diseases associated with the expression of MUC5AC
#287Dimeric binding proteins based on modified ubiquitins
#288Agonists and antagonists of the urotensinergic system
#289In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
#290Cancer Imaging and Treatment
#291Vitamin-targeted imaging agents
#292Tc imaging agents and methods of use
#293Imaging beta cell mass
#294ARSENIC COMPLEXES FOR POTENTIAL DIAGNOSTIC APPLICATIONS
#295Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
#296CANCER IMAGING AND TREATMENT
#297Technetium labelled peptides
#298RGD mimetic γ-AApeptides and methods of use
#299Radiolabelled octreotate analogues as PET tracers
#300Molecular probes for multimodality imaging of anionic membrane surfaces